Cost-Effectiveness Analysis Of Panitumumab + Folfox...

Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia

Vargas-Valencia, J, Garcia Perlaza, J
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.1188
Date:
November, 2015
File:
PDF, 52 KB
english, 2015
Conversion to is in progress
Conversion to is failed